T1	p 25 43	prostatic cancer .
T2	p 162 213	previously untreated patients with prostatic cancer
T3	p 623 653	patients with advanced disease
T4	i 238 317	dose Stilboestrol versus Cyproterone acetate versus Medroxyprogesterone acetate
T5	i 723 749	Adriamycin or Procarbazine
T6	o 752 776	Toxicity and early death